The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Atrial Fibrillation Devices-Global Market Insights and Sales Trends 2025

Atrial Fibrillation Devices-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1824082

No of Pages : 119

Ask Your Query
Synopsis
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF.
The global Atrial Fibrillation Devices market size is expected to reach US$ 5972 million by 2029, growing at a CAGR of 10.8% from 2023 to 2029. The market is mainly driven by the significant applications of Atrial Fibrillation Devices in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Atrial Fibrillation Devices market. Catheter Ablation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Maze Surgery segment is estimated at % CAGR for the next seven-year period.
The leading manufacturers of atrial fibrillation devices include Abbott, Boston Scientific, Biosense Webster, etc, with the top 2 accounting for about 60%.
North America is the largest market with about 37%, followed by Europe with about 27%.In terms of product, catheter ablation is the largest segment, with a share over 88%. And in terms of application, the largest application is ambulatory surgical centers, followed by hospitals.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atrial Fibrillation Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atrial Fibrillation Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atrial Fibrillation Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atrial Fibrillation Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atrial Fibrillation Devices covered in this report include Abbott, Boston Scientific, Biosense Webster, Medtronic, Japan Lifeline, AtriCure, Biotronik, Philips and Synaptic Medical, etc.
The global Atrial Fibrillation Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical
Johnson & Johnson
Global Atrial Fibrillation Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atrial Fibrillation Devices market, Segment by Type:
Catheter Ablation
Maze Surgery
Global Atrial Fibrillation Devices market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atrial Fibrillation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atrial Fibrillation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Atrial Fibrillation Devices Market Overview
1.1 Atrial Fibrillation Devices Product Overview
1.2 Atrial Fibrillation Devices Market Segment by Type
1.2.1 Catheter Ablation
1.2.2 Maze Surgery
1.3 Global Atrial Fibrillation Devices Market Size by Type
1.3.1 Global Atrial Fibrillation Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Atrial Fibrillation Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Atrial Fibrillation Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Atrial Fibrillation Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Atrial Fibrillation Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Atrial Fibrillation Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Atrial Fibrillation Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Atrial Fibrillation Devices Sales Breakdown by Type (2018-2023)
2 Global Atrial Fibrillation Devices Market Competition by Company
2.1 Global Top Players by Atrial Fibrillation Devices Sales (2018-2023)
2.2 Global Top Players by Atrial Fibrillation Devices Revenue (2018-2023)
2.3 Global Top Players by Atrial Fibrillation Devices Price (2018-2023)
2.4 Global Top Manufacturers Atrial Fibrillation Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Atrial Fibrillation Devices Market Competitive Situation and Trends
2.5.1 Atrial Fibrillation Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Atrial Fibrillation Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atrial Fibrillation Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Atrial Fibrillation Devices Market
2.8 Key Manufacturers Atrial Fibrillation Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Atrial Fibrillation Devices Status and Outlook by Region
3.1 Global Atrial Fibrillation Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Atrial Fibrillation Devices Historic Market Size by Region
3.2.1 Global Atrial Fibrillation Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Atrial Fibrillation Devices Sales in Value by Region (2018-2023)
3.2.3 Global Atrial Fibrillation Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Atrial Fibrillation Devices Forecasted Market Size by Region
3.3.1 Global Atrial Fibrillation Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Atrial Fibrillation Devices Sales in Value by Region (2024-2029)
3.3.3 Global Atrial Fibrillation Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Atrial Fibrillation Devices by Application
4.1 Atrial Fibrillation Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Others
4.2 Global Atrial Fibrillation Devices Market Size by Application
4.2.1 Global Atrial Fibrillation Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Atrial Fibrillation Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Atrial Fibrillation Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Atrial Fibrillation Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Atrial Fibrillation Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Atrial Fibrillation Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Atrial Fibrillation Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Atrial Fibrillation Devices Sales Breakdown by Application (2018-2023)
5 North America Atrial Fibrillation Devices by Country
5.1 North America Atrial Fibrillation Devices Historic Market Size by Country
5.1.1 North America Atrial Fibrillation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Atrial Fibrillation Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Atrial Fibrillation Devices Sales in Value by Country (2018-2023)
5.2 North America Atrial Fibrillation Devices Forecasted Market Size by Country
5.2.1 North America Atrial Fibrillation Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Atrial Fibrillation Devices Sales in Value by Country (2024-2029)
6 Europe Atrial Fibrillation Devices by Country
6.1 Europe Atrial Fibrillation Devices Historic Market Size by Country
6.1.1 Europe Atrial Fibrillation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Atrial Fibrillation Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Atrial Fibrillation Devices Sales in Value by Country (2018-2023)
6.2 Europe Atrial Fibrillation Devices Forecasted Market Size by Country
6.2.1 Europe Atrial Fibrillation Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Atrial Fibrillation Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Atrial Fibrillation Devices by Region
7.1 Asia-Pacific Atrial Fibrillation Devices Historic Market Size by Region
7.1.1 Asia-Pacific Atrial Fibrillation Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Atrial Fibrillation Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Atrial Fibrillation Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Atrial Fibrillation Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Atrial Fibrillation Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Atrial Fibrillation Devices Sales in Value by Region (2024-2029)
8 Latin America Atrial Fibrillation Devices by Country
8.1 Latin America Atrial Fibrillation Devices Historic Market Size by Country
8.1.1 Latin America Atrial Fibrillation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Atrial Fibrillation Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Atrial Fibrillation Devices Sales in Value by Country (2018-2023)
8.2 Latin America Atrial Fibrillation Devices Forecasted Market Size by Country
8.2.1 Latin America Atrial Fibrillation Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Atrial Fibrillation Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Atrial Fibrillation Devices by Country
9.1 Middle East and Africa Atrial Fibrillation Devices Historic Market Size by Country
9.1.1 Middle East and Africa Atrial Fibrillation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Atrial Fibrillation Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Atrial Fibrillation Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Atrial Fibrillation Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Atrial Fibrillation Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Atrial Fibrillation Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Atrial Fibrillation Devices Products Offered
10.1.5 Abbott Recent Development
10.2 Boston Scientific
10.2.1 Boston Scientific Company Information
10.2.2 Boston Scientific Introduction and Business Overview
10.2.3 Boston Scientific Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boston Scientific Atrial Fibrillation Devices Products Offered
10.2.5 Boston Scientific Recent Development
10.3 Biosense Webster
10.3.1 Biosense Webster Company Information
10.3.2 Biosense Webster Introduction and Business Overview
10.3.3 Biosense Webster Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Biosense Webster Atrial Fibrillation Devices Products Offered
10.3.5 Biosense Webster Recent Development
10.4 Medtronic
10.4.1 Medtronic Company Information
10.4.2 Medtronic Introduction and Business Overview
10.4.3 Medtronic Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Medtronic Atrial Fibrillation Devices Products Offered
10.4.5 Medtronic Recent Development
10.5 Japan Lifeline
10.5.1 Japan Lifeline Company Information
10.5.2 Japan Lifeline Introduction and Business Overview
10.5.3 Japan Lifeline Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Japan Lifeline Atrial Fibrillation Devices Products Offered
10.5.5 Japan Lifeline Recent Development
10.6 AtriCure
10.6.1 AtriCure Company Information
10.6.2 AtriCure Introduction and Business Overview
10.6.3 AtriCure Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AtriCure Atrial Fibrillation Devices Products Offered
10.6.5 AtriCure Recent Development
10.7 Biotronik
10.7.1 Biotronik Company Information
10.7.2 Biotronik Introduction and Business Overview
10.7.3 Biotronik Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biotronik Atrial Fibrillation Devices Products Offered
10.7.5 Biotronik Recent Development
10.8 Philips
10.8.1 Philips Company Information
10.8.2 Philips Introduction and Business Overview
10.8.3 Philips Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Philips Atrial Fibrillation Devices Products Offered
10.8.5 Philips Recent Development
10.9 Synaptic Medical
10.9.1 Synaptic Medical Company Information
10.9.2 Synaptic Medical Introduction and Business Overview
10.9.3 Synaptic Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Synaptic Medical Atrial Fibrillation Devices Products Offered
10.9.5 Synaptic Medical Recent Development
10.10 Osypka AG
10.10.1 Osypka AG Company Information
10.10.2 Osypka AG Introduction and Business Overview
10.10.3 Osypka AG Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Osypka AG Atrial Fibrillation Devices Products Offered
10.10.5 Osypka AG Recent Development
10.11 MicroPort Scientific
10.11.1 MicroPort Scientific Company Information
10.11.2 MicroPort Scientific Introduction and Business Overview
10.11.3 MicroPort Scientific Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 MicroPort Scientific Atrial Fibrillation Devices Products Offered
10.11.5 MicroPort Scientific Recent Development
10.12 CardioFocus
10.12.1 CardioFocus Company Information
10.12.2 CardioFocus Introduction and Business Overview
10.12.3 CardioFocus Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CardioFocus Atrial Fibrillation Devices Products Offered
10.12.5 CardioFocus Recent Development
10.13 Lepu Medical
10.13.1 Lepu Medical Company Information
10.13.2 Lepu Medical Introduction and Business Overview
10.13.3 Lepu Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Lepu Medical Atrial Fibrillation Devices Products Offered
10.13.5 Lepu Medical Recent Development
10.14 APT Med
10.14.1 APT Med Company Information
10.14.2 APT Med Introduction and Business Overview
10.14.3 APT Med Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 APT Med Atrial Fibrillation Devices Products Offered
10.14.5 APT Med Recent Development
10.15 TZ Medical
10.15.1 TZ Medical Company Information
10.15.2 TZ Medical Introduction and Business Overview
10.15.3 TZ Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.15.4 TZ Medical Atrial Fibrillation Devices Products Offered
10.15.5 TZ Medical Recent Development
10.16 Johnson & Johnson
10.16.1 Johnson & Johnson Company Information
10.16.2 Johnson & Johnson Introduction and Business Overview
10.16.3 Johnson & Johnson Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Johnson & Johnson Atrial Fibrillation Devices Products Offered
10.16.5 Johnson & Johnson Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Atrial Fibrillation Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Atrial Fibrillation Devices Industrial Chain Analysis
11.4 Atrial Fibrillation Devices Market Dynamics
11.4.1 Atrial Fibrillation Devices Industry Trends
11.4.2 Atrial Fibrillation Devices Market Drivers
11.4.3 Atrial Fibrillation Devices Market Challenges
11.4.4 Atrial Fibrillation Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Atrial Fibrillation Devices Distributors
12.3 Atrial Fibrillation Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock